Search Results - "Forster CL"

Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling.

Authors: Macaulay ARK Yang J Price MA et al.

Source: The British journal of dermatology [Br J Dermatol] 2024 Dec 23; Vol. 192 (1), pp. 104-117.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activity.

Authors: Schulte AJ Lewellen M Durose W et al.

Source: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2025 Sep; Vol. 392 (9), pp. 103674. Date of Electronic Publication: 2025 Aug 18.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE

Bioinformatics tools and experimental analysis combination for production of specific scFv against CD133.

Authors: Mohammadi R Kazemi B Yarian F et al.

Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2025 Aug; Vol. 398 (8), pp. 10523-10538. Date of Electronic Publication: 2025 Feb 27.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE

Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.

Authors: Tarullo SE He Y Daughters C et al.

Source: The Journal of pathology [J Pathol] 2023 Jul; Vol. 260 (3), pp. 289-303. Date of Electronic Publication: 2023 Apr 26.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE

MYO5A::FGFR1 represents a novel fusion event in pediatric low-grade glioma.

Authors: Galvin RT Zheng C Fitzpatrick G et al.

Source: Neuro-oncology advances [Neurooncol Adv] 2023 Feb 23; Vol. 5 (1), pp. vdad017. Date of Electronic Publication: 2023 Feb 23 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

Assessing blood-brain barrier (BBB) integrity in an Alzheimer's disease mouse model: is the BBB globally or locally disrupted?

Authors: Nozohouri, Ehsan Noorani, Behnam Patel, Dhavalkumar et al.

Source: Fluids & Barriers of the CNS. 7/23/2025, Vol. 22 Issue 1, p1-15. 15p.

5-Hydroxymethylcytosine: a key epigenetic mark in cancer and chemotherapy response.

Authors: Kharat, Suhas S. Sharan, Shyam K.

Source: Epigenetics & Chromatin. 11/17/2025, Vol. 18 Issue 1, p1-12. 12p.

HMMR in human cancers: regulatory mechanism and biological function.

Authors: Hu, Yanghao Zhang, Yifei He, Jiali et al.

Source: Journal of Translational Medicine. 11/18/2025, Vol. 23 Issue 1, p1-28. 28p.

⁵⁶Fe-ion Exposure Increases the Incidence of Lung and Brain Tumors at a Similar Rate in Male and Female Mice.

Authors: Finkelstein, Sophie R. Patel, Rutulkumar Deland, Katherine et al.

Source: Radiation Research. Nov2024, Vol. 202 Issue 5, p734-744. 11p.

Acute targeting of N-terminal tau protein has long-lasting beneficial effects in Tg2576 APP/Aβ mouse model by reducing cognitive impairment, cerebral Aβ-amyloidosis, synaptic remodeling and microgliosis later in life.

Authors: Latina, Valentina De Introna, Margherita Malerba, Francesca et al.

Source: Acta Neuropathologica Communications. 5/29/2025, Vol. 13 Issue 1, p1-31. 31p.

Two mouse models of Alzheimer's disease accumulate amyloid at different rates and have distinct Aβ oligomer profiles unaltered by ablation of cellular prion protein.

Authors: Purro, Silvia A. Farmer, Michael Noble, Elizabeth et al.

Source: PLoS ONE. 11/17/2023, Vol. 18 Issue 11, p1-16. 16p.

UHRF2 regulates cell cycle, epigenetics and gene expression to control the timing of retinal progenitor and ganglion cell differentiation.

Authors: Wang X Sarver AL Han Q et al.

Source: Development (Cambridge, England) [Development] 2022 Mar 15; Vol. 149 (6). Date of Electronic Publication: 2022 Mar 14.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Company Of Biologists Limited Country of Publication: England NLM ID: 8701744 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-9129 (Electronic) Linking ISSN: 09501991 NLM ISO Abbreviation: Development Subsets: MEDLINE

Cross-species identification of PIP5K1-, splicing- and ubiquitin-related pathways as potential targets for RB1-deficient cells.

Authors: Parkhitko, Andrey A. Singh, Arashdeep Hsieh, Sharon et al.

Source: PLoS Genetics. 2/16/2021, Vol. 17 Issue 2, p1-31. 31p.

ASPM promotes the progression of esophageal squamous cell carcinoma by upregulating the expression of HMMR.

Authors: Qin Z Yang J Liu K et al.

Source: Cancer cell international [Cancer Cell Int] 2026 Apr 22. Date of Electronic Publication: 2026 Apr 22.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101139795 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1475-2867 (Print) Linking ISSN: 14752867 NLM ISO Abbreviation: Cancer Cell Int

Anticancer activity of IRAK‐4 inhibitors against canine lymphoid malignancies.

Authors: Park, Jun‐Hyeong Lee, Jeong‐Hwa An, Ju‐Hyun et al.

Source: Veterinary & Comparative Oncology. Sep2022, Vol. 20 Issue 3, p632-640. 9p.

Nonviral mcDNA-mediated bispecific CAR T cells kill tumor cells in an experimental mouse model of hepatocellular carcinoma.

Authors: Wang, Hezhi Wang, Xiaoxiao Ye, Xueshuai et al.

Source: BMC Cancer. 7/25/2022, Vol. 22 Issue 1, p1-18. 18p.

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease.

Authors: Puntambekar, Shweta S. Moutinho, Miguel Lin, Peter Bor-Chian et al.

Source: Molecular Neurodegeneration. 6/28/2022, Vol. 17 Issue 1, p1-21. 21p.

Investigation of the role of the miR17-92 cluster in BMP9-induced osteoblast lineage commitment.

Authors: Zhang, Yunyuan Jing, Xuran Li, Zhongzhu et al.

Source: Journal of Orthopaedic Surgery & Research. 10/30/2021, Vol. 16 Issue 1, p1-10. 10p.

The prognostic value of ubiquitin/ubiquitin-like-related genes along with immune cell infiltration and clinicopathological features in osteosarcoma.

Authors: Wen, Jian Wan, Lijia Chen, Wenming et al.

Source: Journal of Orthopaedic Surgery & Research. 6/15/2024, Vol. 19 Issue 1, p1-20. 20p.

The role of CD133 in cancer: a concise review.

Authors: Glumac, Paige M. LeBeau, Aaron M.

Source: Clinical & Translational Medicine. Dec2018, Vol. 7 Issue 1, p1-14. 14p.